ロード中...
Opioid system in L-DOPA-induced dyskinesia
L-3, 4-Dihydroxyphenylalanine (L-DOPA)-induced dyskinesia (LID) is a major clinical complication in the treatment of Parkinson’s disease (PD). This debilitating side effect likely reflects aberrant compensatory responses for a combination of dopaminergic neuron denervation and repeated L-DOPA admini...
保存先:
| 出版年: | Transl Neurodegener |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5240307/ https://ncbi.nlm.nih.gov/pubmed/28105331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40035-017-0071-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|